Detalhe da pesquisa
1.
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 2022 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988836
2.
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels.
Ann Surg Oncol
; 29(Suppl 3): 616-617, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930113